Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
2.
eNeuro ; 8(5)2021.
Article in English | MEDLINE | ID: mdl-34417284

ABSTRACT

Neuroscience has been transformed by the ability to genetically modify inbred mice, including the ability to express fluorescent markers specific to cell types or activation states. This approach has been put to particularly good effect in the study of the innate immune cells of the brain, microglia. These specialized macrophages are exceedingly small and complex, but also highly motile and mobile. To date, there have been no tools similar to those in mice available for studying these fundamental cells in the rat brain, and we seek to fill that gap with the generation of the genetically modified Sprague Dawley rat line: SD-Tg(Iba1-EGFP)Mmmc Using CRISPR-Cas/9 technology, we knocked in EGFP to the promoter of the gene Iba1 With four male and three female founders confirmed by quantitative PCR analysis to have appropriate and specific insertion, we established a breeding colony with at least three generations of backcrosses to obtain stable and reliable Iba1-EGFP expression. The specificity of EGFP expression to microglia was established by flow cytometry for CD45low/CD11b+ cells and by immunohistochemistry. Microglial EGFP expression was detected in neonates and persisted into adulthood. Blood macrophages and monocytes were found to express low levels of EGFP, as expected. Last, we show that EGFP expression is suitable for live imaging of microglia processes in acute brain slices and via intravital two-photon microscopy.


Subject(s)
Microglia , Rodentia , Animals , Female , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Rats , Rats, Sprague-Dawley , Rats, Transgenic
3.
Endocrinology ; 161(6)2020 06 01.
Article in English | MEDLINE | ID: mdl-32270188

ABSTRACT

Sex is an essential biological variable that significantly impacts multiple aspects of neural functioning in both the healthy and diseased brain. Sex differences in brain structure and function are organized early in development during the critical period of sexual differentiation. While decades of research establish gonadal hormones as the primary modulators of this process, new research has revealed a critical, and perhaps underappreciated, role of the neuroimmune system in sex-specific brain development. The immune and endocrine systems are tightly intertwined and share processes and effector molecules that influence the nervous system. Thus, a natural question is whether endocrine-immune crosstalk contributes to sexual differentiation of the brain. In this mini-review, we first provide a conceptual framework by classifying the major categories of neural sex differences and review the concept of sexual differentiation of the brain, a process occurring early in development and largely controlled by steroid hormones. Next, we describe developmental sex differences in the neuroimmune system, which may represent targets or mediators of the sexual differentiation process. We then discuss the overwhelming evidence in support of crosstalk between the neuroendocrine and immune systems and highlight recent examples that shape sex differences in the brain. Finally, we review how early life events can perturb sex-specific neurodevelopment via aberrant immune activation.


Subject(s)
Brain/growth & development , Immune System/physiology , Neurosecretory Systems/metabolism , Animals , Brain/physiology , Gonadal Hormones/metabolism , Humans , Neuroimmunomodulation , Sex Differentiation , Sex Factors
4.
Neuron ; 102(2): 435-449.e6, 2019 04 17.
Article in English | MEDLINE | ID: mdl-30827729

ABSTRACT

Brain sex differences are established developmentally and generate enduring changes in circuitry and behavior. Steroid-mediated masculinization of the rat amygdala during perinatal development produces higher levels of juvenile rough-and-tumble play by males. This sex difference in social play is highly conserved across mammals, yet the mechanisms by which it is established are unknown. Here, we report that androgen-induced increases in endocannabinoid tone promote microglia phagocytosis during a critical period of amygdala development. Phagocytic microglia engulf more viable newborn cells in males; in females, less phagocytosis allows more astrocytes to survive to the juvenile age. Blocking complement-dependent phagocytosis in males increases astrocyte survival and prevents masculinization of play. Moreover, increased astrocyte density in the juvenile amygdala reduces neuronal excitation during play. These findings highlight novel mechanisms of brain development whereby endocannabinoids induce microglia phagocytosis to regulate newborn astrocyte number and shape the sexual differentiation of social circuitry and behavior. VIDEO ABSTRACT.


Subject(s)
Amygdala/metabolism , Astrocytes/metabolism , Endocannabinoids/metabolism , Microglia/physiology , Phagocytosis/physiology , Play and Playthings , Sex Characteristics , Social Behavior , Amygdala/cytology , Amygdala/drug effects , Amygdala/growth & development , Androgen Antagonists/pharmacology , Androgens/metabolism , Androgens/pharmacology , Animals , Animals, Newborn , Arachidonic Acids/metabolism , Behavior, Animal , Cell Survival , Complement System Proteins/metabolism , Complement System Proteins/physiology , Endocannabinoids/physiology , Female , Flutamide/pharmacology , Glycerides/metabolism , Male , Microglia/drug effects , Phagocytosis/drug effects , Polyunsaturated Alkamides/metabolism , Rats , Testosterone/metabolism , Testosterone/pharmacology
5.
Exp Neurol ; 317: 168-179, 2019 07.
Article in English | MEDLINE | ID: mdl-30831070

ABSTRACT

The response of the developing brain to traumatic injury is different from the response of the mature, adult brain. There are critical developmental trajectories in the young brain, whereby injury can lead to long term functional abnormalities. Emerging preclinical and clinical literature supports the presence of significant sex differences in both the response to and the recovery from pediatric traumatic brain injury (TBI). These sex differences are seen at all pediatric ages, including neonates/infants, pre-pubertal children, and adolescents. As importantly, the response to neuroprotective therapies or treatments can differ between male and females subjects. These sex differences can result from several biologic origins, and may manifest differently during the various phases of brain and body development. Recognizing and understanding these potential sex differences is crucial, and should be considered in both preclinical and clinical studies of pediatric TBI.


Subject(s)
Brain Injuries, Traumatic , Sex Characteristics , Adolescent , Animals , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male
6.
Sci Rep ; 8(1): 1396, 2018 01 23.
Article in English | MEDLINE | ID: mdl-29362383

ABSTRACT

The genetic and environmental factors that contribute to pair bonding behaviour remain poorly understood. Prairie voles (Microtus ochrogaster) often, but not always, form stable pair bonds and present an ideal model species for investigating the genetic and environmental factors that influence monogamy. Here, we assessed variation in partner preference, a measure of pair bonding, and related social behaviours in a population of laboratory-reared prairie voles under controlled environmental conditions. We evaluated to what extent variation in these behaviours correlate with vasopressin 1a receptor (V1aR) expression in the ventral pallidum (VP) and retrosplenial cortex (RSC), and estimated the heritability of these behaviours and V1aR expression. We found substantial variation in partner preference and measures of aggression, paternal care, and anxiety-like behaviours, but no correlation between these traits. We also found variation in V1aR density in the VP and RSC can account for behavioural components of paternal care and aggression, but not in partner preference. Heritability estimates of variation in partner preference were low, yet heritability estimates for V1aR expression were high, indicating that the extensive variation in partner preference observed within this population is due largely to environmental plasticity.


Subject(s)
Arvicolinae/physiology , Receptors, Vasopressin/metabolism , Social Behavior , Animals , Basal Forebrain/metabolism , Female , Male , Mating Preference, Animal , Pair Bond
7.
Neurotoxicology ; 65: 207-220, 2018 03.
Article in English | MEDLINE | ID: mdl-29097150

ABSTRACT

Bisphenol A (BPA) is a widely recognized endocrine disruptor prevalent in many household items. Because experimental and epidemiological data suggest links between prenatal BPA exposure and altered affective behaviors in children, even at levels below the current US FDA No Observed Adverse Effect Level (NOAEL) of 5mg/kg body weight (bw)/day, there is concern that early life exposure may alter neurodevelopment. The current study was conducted as part of the CLARITY-BPA (Consortium Linking Academic and Regulatory Insights on BPA Toxicity) program and examined the full amygdalar transcriptome on postnatal day (PND) 1, with the hypothesis that prenatal BPA exposure would alter the expression of genes and pathways fundamental to sex-specific affective behaviors. NCTR Sprague-Dawley dams were gavaged from gestational day 6 until parturition with BPA (2.5, 25, 250, 2500, or 25000µg/kg bw/day), a reference estrogen (0.05 or 0.5µg ethinyl estradiol (EE2)/kg bw/day), or vehicle. PND 1 amygdalae were microdissected and gene expression was assessed with qRT-PCR (all exposure groups) and RNAseq (vehicle, 25 and 250µg BPA, and 0.5µg EE2 groups only). Our results demonstrate that that prenatal BPA exposure can disrupt the transcriptome of the neonate amygdala, at doses below the FDA NOAEL, in a sex-specific manner and indicate that the female amygdala may be more sensitive to BPA exposure during fetal development. We also provide additional evidence that developmental BPA exposure can interfere with estrogen, oxytocin, and vasopressin signaling pathways in the developing brain and alter signaling pathways critical for synaptic organization and transmission.


Subject(s)
Amygdala/drug effects , Amygdala/metabolism , Benzhydryl Compounds/toxicity , Phenols/toxicity , Prenatal Exposure Delayed Effects/metabolism , Transcriptome/drug effects , Animals , Animals, Newborn , Dose-Response Relationship, Drug , Ethinyl Estradiol/pharmacology , Female , Male , Pregnancy , Rats , Sex Characteristics , Signal Transduction/drug effects
8.
Neurotoxicology ; 63: 33-42, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28890130

ABSTRACT

Bisphenol A (BPA) is a high volume endocrine disrupting chemical found in a wide variety of products including plastics and epoxy resins. Human exposure is nearly ubiquitous, and higher in children than adults. Because BPA has been reported to interfere with sex steroid hormone signaling, there is concern that developmental exposure, even at levels below the current FDA No Observed Adverse Effect Level (NOAEL) of 5mg/kg body weight (bw)/day, can disrupt brain sexual differentiation. The current studies were conducted as part of the CLARITY-BPA (Consortium Linking Academic and Regulatory Insights on BPA Toxicity) program and tested the hypothesis that perinatal BPA exposure would induce morphological changes in hormone sensitive, sexually dimorphic brain regions. Sprague-Dawley rats were randomly assigned to 5 groups: BPA (2.5, 25, or 2500µg/kgbw/day), a reference estrogen (0.5µg ethinylestradiol (EE2)/kgbw/day), or vehicle. Exposure occurred by gavage to the dam from gestational day 6 until parturition, and then to the offspring from birth through weaning. Unbiased stereology was used to quantify the volume of the sexually dimorphic nucleus (SDN), the anteroventral periventricular nucleus (AVPV), the posterodorsal portion of the medial amygdala (MePD), and the locus coeruleus (LC) at postnatal day 28. No appreciable effects of BPA were observed on the volume of the SDN or LC. However, AVPV volume was enlarged in both sexes, even at levels below the FDA NOAEL. Collectively, these data suggest the developing brain is vulnerable to endocrine disruption by BPA at exposure levels below previous estimates by regulatory agencies.


Subject(s)
Benzhydryl Compounds/toxicity , Brain/pathology , Endocrine Disruptors/toxicity , Phenols/toxicity , Prenatal Exposure Delayed Effects/chemically induced , Sex Characteristics , Analysis of Variance , Animals , Animals, Newborn , Brain/drug effects , Dose-Response Relationship, Drug , Estrogens/pharmacology , Ethinyl Estradiol/pharmacology , Female , Male , Pregnancy , Rats , Rats, Sprague-Dawley
9.
Sci Rep ; 7(1): 7118, 2017 08 02.
Article in English | MEDLINE | ID: mdl-28769031

ABSTRACT

Firemaster® 550 (FM 550) is a commercial flame retardant mixture of brominated and organophosphate compounds applied to polyurethane foam used in furniture and baby products. Due to widespread human exposure, and structural similarities with known endocrine disruptors, concerns have been raised regarding possible toxicity. We previously reported evidence of sex specific behavioral effects in rats resulting from developmental exposure. The present study expands upon this prior finding by testing for a greater range of behavioral effects, and measuring the accumulation of FM 550 compounds in placental tissue. Wistar rat dams were orally exposed to FM 550 during gestation (0, 300 or 1000 µg/day; GD 9 - 18) for placental measurements or perinatally (0, 100, 300 or 1000 µg/day; GD 9 - PND 21) to assess activity and anxiety-like behaviors. Placental accumulation was dose dependent, and in some cases sex specific, with the brominated components reaching the highest levels. Behavioral changes were predominantly associated with a loss or reversal of sex differences in activity and anxiety-like behaviors. These findings demonstrate that environmental chemicals may sex-dependently accumulate in the placenta. That sex-biased exposure might translate to sex-specific adverse outcomes such as behavioral deficits is a possibility that merits further investigation.


Subject(s)
Behavior, Animal/drug effects , Flame Retardants/adverse effects , Placenta/drug effects , Placenta/metabolism , Age Factors , Analysis of Variance , Animals , Dose-Response Relationship, Drug , Female , Flame Retardants/analysis , Male , Molecular Structure , Pregnancy , Rats , Rats, Wistar , Sex Factors
10.
Endocrinology ; 157(10): 3856-3872, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27571134

ABSTRACT

Bisphenol A (BPA) is an endocrine disrupting, high volume production chemical found in a variety of products. Evidence of prenatal exposure has raised concerns that developmental BPA may disrupt sex-specific brain organization and, consequently, induce lasting changes on neurophysiology and behavior. We and others have shown that exposure to BPA at doses below the no-observed-adverse-effect level can disrupt the sex-specific expression of estrogen-responsive genes in the neonatal rat brain including estrogen receptors (ERs). The present studies, conducted as part of the Consortium Linking Academic and Regulatory Insights of BPA Toxicity program, expanded this work by examining the hippocampal and hypothalamic transcriptome on postnatal day 1 with the hypothesis that genes sensitive to estrogen and/or sexually dimorphic in expression would be altered by prenatal BPA exposure. NCTR Sprague-Dawley dams were gavaged from gestational day 6 until parturition with BPA (0-, 2.5-, 25-, 250-, 2500-, or 25 000-µg/kg body weight [bw]/d). Ethinyl estradiol was used as a reference estrogen (0.05- or 0.5-µg/kg bw/d). Postnatal day 1 brains were microdissected and gene expression was assessed with RNA-sequencing (0-, 2.5-, and 2500-µg/kg bw BPA groups only) and/or quantitative real-time PCR (all exposure groups). BPA-related transcriptional changes were mainly confined to the hypothalamus. Consistent with prior observations, BPA induced sex-specific effects on hypothalamic ERα and ERß (Esr1 and Esr2) expression and hippocampal and hypothalamic oxytocin (Oxt) expression. These data demonstrate prenatal BPA exposure, even at doses below the current no-observed-adverse-effect level, can alter gene expression in the developing brain.


Subject(s)
Benzhydryl Compounds/toxicity , Estrogens, Non-Steroidal/toxicity , Hippocampus/drug effects , Hypothalamus/drug effects , Phenols/toxicity , Transcriptome/drug effects , Administration, Oral , Animals , Animals, Newborn , Benzhydryl Compounds/administration & dosage , Estrogens, Non-Steroidal/administration & dosage , Female , Gene Expression/drug effects , Hippocampus/metabolism , Hypothalamus/metabolism , Male , Phenols/administration & dosage , Random Allocation , Rats , Rats, Sprague-Dawley , Sex Characteristics
SELECTION OF CITATIONS
SEARCH DETAIL
...